Linagliptin
Products in Health Canada’s databases that list Linagliptin as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 6
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 22
- Products in all
- 6
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| JENTADUETO (2.5 MG) | 02403250 | Marketed | Boehringer Ingelheim (Canada) Ltd. | |
| JENTADUETO (2.5 MG) | 02403269 | Marketed | Boehringer Ingelheim (Canada) Ltd. | |
| JENTADUETO (2.5 MG) | 02403277 | Marketed | Boehringer Ingelheim (Canada) Ltd. | |
| TRAJENTA (5 MG) | 02370921 | Marketed | Boehringer Ingelheim (Canada) Ltd. | |
| GLYXAMBI (5 MG) | 02459752 | Cancelled Post Market | Boehringer Ingelheim (Canada) Ltd. | |
| GLYXAMBI (5 MG) | 02459760 | Cancelled Post Market | Boehringer Ingelheim (Canada) Ltd. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- JENTADUETOJune 8, 2023 · NOC 30962
- GLYXAMBIApril 4, 2023 · NOC 30472
- TRAJENTAJune 22, 2021 · NOC 26124
- GLYXAMBIMarch 17, 2021 · NOC 25461
- JENTADUETOMarch 16, 2021 · NOC 25437
- TRAJENTAFebruary 26, 2021 · NOC 25316
- JENTADUETOJune 15, 2020 · NOC 23790
- TRAJENTAMay 19, 2020 · NOC 23633
- JENTADUETOApril 9, 2020 · NOC 23437
- TRAJENTAMarch 2, 2020 · NOC 23299
- TRAJENTANovember 8, 2019 · NOC 22888
- JENTADUETOMay 24, 2019 · NOC 22190
- TRAJENTAMay 22, 2019 · NOC 22186
- GLYXAMBIMay 15, 2019 · NOC 22161
- TRAJENTAOctober 11, 2018 · NOC 21443
- GLYXAMBIMay 29, 2018 · NOC 20905
- GLYXAMBIApril 20, 2018 · NOC 20770
- GLYXAMBIDecember 15, 2016 · NOC 18771
- JENTADUETODecember 9, 2013 · NOC 15050
- JENTADUETOMarch 7, 2013 · NOC 14192
- TRAJENTAAugust 3, 2012 · NOC 13547
- TRAJENTAJuly 28, 2011 · NOC 12518